Is Assertio Holdings, Inc. (ASRT) a Buy, Sell, or Hold?
NASDAQ : ASRT
Assertio Holdings, Inc.
$23.5 USD
$0 (0.0%)
- Volume
- 270.19K
- Average Volume
- 327.45K
- Market Capitalization
- $151.86M
- P/E Ratio
- -4.24
- Dividend Yield
- 0.00%
- Price Target
- $22.65
- Year High
- $23.50
- Year Low
- $8.61
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.82
Company Overview
NASDAQ
Mark L. Reisenauer
Drug Manufacturers - Specialty & Generic
Healthcare
ASRT
58
US
USD
Liquidity Metrics
0.53
1.82
1.57
0.37
0.00
Sales & Valuation
$118.71M
1.49
2.00
-21.45
-1.10
Profitability
-$4.74
-$30.38M
-34.94%
-34.71%
-38.72%
-16.89%
P/E Metrics
-4.24
0.11
0.11
Analyst Price Target & Rating
$22.65
$23.50
$21.80
0/5
18 Analysts
3.75%
Poll Results
About Assertio Holdings, Inc. (NASDAQ:ASRT) Stock
Assertio Holdings, Inc. is a specialized pharmaceutical company focused on developing and commercializing therapeutic solutions across key medical domains, including neurology, hospital care, and pain and inflammation management. Among its portfolio, Assertio offers INDOCIN, available as both an oral solution and a suppository. This medication addresses conditions such as moderate to severe rheumatoid arthritis (including acute flare-ups), ankylosing spondylitis, osteoarthritis, acute painful shoulder, and gouty arthritis. The company's offerings also encompass CAMBIA, an NSAID specifically formulated to alleviate symptoms associated with migraine headaches, including nausea, light sensitivity (photophobia), and sound sensitivity (phonophobia). Zipsor, another NSAID, is indicated for manag ... ing mild to moderate acute pain. For more significant short-term pain relief, SPRIX, also an NSAID, provides analgesia comparable to opioid-level treatments for moderate to moderately severe pain. Rounding out its product line is Otrexup, a prescription methotrexate delivered via a convenient single-dose auto-injector. This therapy targets severe, active rheumatoid arthritis in adults and active polyarticular juvenile idiopathic arthritis in pediatric patients. Initially incorporated as Assertio Therapeutics, Inc. in 1995, the organization rebranded to Assertio Holdings, Inc. in May 2020 and maintains its corporate headquarters in Lake Forest, Illinois.
2026-06-16 16:30:00
LAKE FOREST, Ill.--(BUSINESS WIRE)--Assertio Holdings, Inc. (Nasdaq: ASRT) (“Assertio” or the “Company”) today announced the successful completion of its previously announced merger (the “Merger”) with Zydus Lifesciences Ltd. (“Zydus Lifesciences”) pursuant to the terms of the Agreement and Plan of Merger, dated as of May 13, 2026 (the “Merger Agreement”), between, among others, the Company, Zydus Worldwide DMCC, a limited liability company incorporated under the laws of the United Arab Emirate.
Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?
2026-06-09 14:00:00
Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 9, 2026
Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?
2026-06-09 13:19:00
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
2026-06-08 22:16:00
MILWAUKEE, June 08, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Assertio (NASDAQ: ASRT) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Zydus.
Are SILA, UNF, ASRT, KW Obtaining Fair Deals for their Shareholders?
2026-05-25 17:00:00
Are SILA, UNF, ASRT, KW Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 25, 2026
Are SILA, UNF, ASRT, KW Obtaining Fair Deals for their Shareholders?
2026-05-25 16:13:00
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
2026-05-19 15:00:00
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (âKSFâ) are investigating the propos
2026-05-19 14:08:00
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Assertio Holdings, Inc. (NasdaqCM: ASRT) to Garda Therapeutics. Under the terms of the proposed transaction, shareholders of Assertio will receive $18.00 per share in cash and a contingent value right. KSF is seeking to determine whether this consideration and the process that led to it are adequate,.
Frequently Asked Questions
-
What is the current Assertio Holdings, Inc. (ASRT) stock price?
-
Assertio Holdings, Inc.(NASDAQ:ASRT) stock price is $23.5 in the last trading session. During the trading session, ASRT stock reached the peak price of $23.5 while $8.61 was the lowest point it dropped to. The percentage change in ASRT stock occurred in the recent session was 0.0% while the dollar amount for the price change in ASRT stock was $0.
-
ASRT's industry and sector of operation?
-
The NASDAQ listed ASRT is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of ASRT?
-
Paul Schwichtenberg | President & Chief Operating Officer
Sam Schlessinger | Executive Vice President & General Counsel
Ajay Patel | Executive Vice President & Chief Financial Officer
Howard J. Franklin | Senior Vice President of Medical
Mark L. Reisenauer | Chief Executive Officer & Director -
How many employees does ASRT have?
-
Number of ASRT employees currently stands at 58. ASRT operates from 100 South Saunders Road, Lake Forest, IL 60045, US.
-
Link for ASRT official website?
-
Official Website of ASRT is: https://www.assertiotx.com
-
How do I contact ASRT?
-
ASRT could be contacted at phone #224 419 7106 and can also be accessed through its website. ASRT operates from 100 South Saunders Road, Lake Forest, IL 60045, US.
-
How many shares of ASRT are traded daily?
-
The average number of ASRT shares traded daily for last 3 months was 327.45K.
-
What is the market cap of ASRT currently?
-
The market value of ASRT currently stands at $151.86M with its latest stock price at $23.5